# Construction and Validation of a Diagnostic Model for Predicting Molecular Residual Disease and Recurrence of Cervical Cancer Based on Circulating Tumor HPV

> **NCT06456112** · — · NOT_YET_RECRUITING · sponsor: **Anhui Provincial Hospital** · enrollment: 83 (estimated)

## Conditions studied

- Cervical Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06456112
- **Lead sponsor:** Anhui Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07-01
- **Primary completion:** 2026-07-30
- **Final completion:** 2026-07-30
- **Target enrollment:** 83 (ESTIMATED)
- **Last updated:** 2024-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06456112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06456112, "Construction and Validation of a Diagnostic Model for Predicting Molecular Residual Disease and Recurrence of Cervical Cancer Based on Circulating Tumor HPV". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06456112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*